Table III.
Summary of major implicated pathways in VHL-associated and sporadic renal tumors.
KEGG ID | KEGG description | KEGG subclass | KEGG class |
---|---|---|---|
Common pathways in both tumor groups | |||
hsa04115 | p53 signaling pathway | Cell growth and death | Cellular processes |
hsa04510 | Focal adhesion | Cellular community | |
hsa04540 | Gap junction | ||
hsa04060 | Cytokine-cytokine receptor interaction | Signaling molecules and interaction | Environmental information processing |
hsa04514 | Cell adhesion molecules (CAMs) | ||
hsa04512 | ECM-receptor interaction | ||
hsa05200 | Pathways in cancer | Cancers: Overview | Human diseases |
hsa03320 | PPAR signaling pathway | Endocrine system | Organismal systems |
hsa04960 | Aldosterone-regulated sodium reabsorption | Excretory system | |
hsa04610 | Complement and coagulation cascades | Immune system | |
hsa04650 | Natural killer cell mediated cytotoxicity | ||
hsa04640 | Hematopoietic cell lineage | ||
hsa04672 | Intestinal immune network for IgA production | ||
hsa04610 | Complement and coagulation cascades | ||
hsa04062 | Chemokine signaling pathway | ||
hsa04612 | Antigen processing and presentation | ||
hsa04621 | NOD-like receptor signaling pathway | ||
hsa04660 | T cell receptor signaling pathway | ||
hsa04670 | Leukocyte transendothelial migration | ||
hsa00532 | Chondroitin sulfate biosynthesis | Glycan biosynthesis and metabolism | Metabolism |
hsa00280 | Valine, leucine and isoleucine degradation | Amino acid metabolism | |
hsa00380 | Tryptophan metabolism | ||
hsa00330 | Arginine and proline metabolism | ||
hsa00260 | Glycine, serine and threonine metabolism | ||
hsa00250 | Alanine, aspartate and glutamate metabolism | ||
hsa00340 | Histidine metabolism | ||
hsa00310 | Lysine degradation | ||
hsa00270 | Cysteine and methionine metabolism | ||
hsa00350 | Tyrosine metabolism | ||
hsa00640 | Propanoate metabolism | Carbohydrate metabolism | |
hsa00650 | Butanoate metabolism | ||
hsa00620 | Pyruvate metabolism | ||
hsa00020 | Citrate cycle (TCA cycle) | ||
hsa00053 | Ascorbate and aldarate metabolism | ||
hsa00010 | Glycolysis/gluconeogenesis | ||
hsa00040 | Pentose and glucuronate interconversions | ||
hsa00500 | Starch and sucrose metabolism | ||
hsa00630 | Glyoxylate and dicarboxylate metabolism | ||
hsa00190 | Oxidative phosphorylation | Energy metabolism | |
hsa00910 | Nitrogen metabolism | ||
hsa00071 | Fatty acid metabolism | Global and overview maps | |
hsa00072 | Synthesis and degradation of ketone bodies | Lipid metabolism | |
hsa00140 | Steroid hormone biosynthesis | ||
hsa00120 | Primary bile acid biosynthesis | ||
hsa00590 | Arachidonic acid metabolism | ||
hsa00062 | Fatty acid elongation in mitochondria | ||
hsa00830 | Retinol metabolism | Metabolism of cofactors and vitamins | |
hsa00410 | β-Alanine metabolism | Metabolism of other amino acids | |
hsa00480 | Glutathione metabolism | ||
hsa00903 | Limonene and pinene degradation | Metabolism of terpenoids and polyketides | |
hsa00982 | Drug metabolism-cytochrome P450 | Xenobiotics biodegradation and metabolism | |
hsa00980 | Metabolism of xenobiotics | ||
by cytochrome P450 | |||
hsa00983 | Drug metabolism-other enzymes | ||
Specific to VHL-associated tumors | |||
hsa04330 | Notch signaling pathway | Signal transduction | Environmental information processing |
hsa00900 | Terpenoid backbone biosynthesis | Metabolism of terpenoids and polyketides | Metabolism |
Specific to sporadic tumors | |||
hsa04110 | Cell cycle | Cell growth and death | Cellular processes |
hsa04630 | Jak-STAT signaling pathway | Signal transduction | Environmental information processing |
hsa04666 | FcγR-mediated phagocytosis | Immune system | Organismal systems |
hsa04662 | B cell receptor signaling pathway | ||
hsa04620 | Toll-like receptor signaling pathway | ||
hsa01040 | Biosynthesis of unsaturated fatty acids | Lipid metabolism | Metabolism |
hsa00100 | Steroid biosynthesis | ||
hsa00360 | Phenylalanine metabolism | Amino acid metabolism |
VHL, von Hippel-Lindau.